Immuno-Oncology in Bladder Cancer: The Urologist's Role - Noah Hahn

Noah Hahn presents the importance of immuno-oncology (IO) - checkpoint inhibitors and their role in early stage non-muscle invasive bladder cancer (NMIBC) as well as in muscle invasive bladder cancer (MIBC). He also discusses the ongoing studies in the IO space that can be practice changing in both of these diseases.  


Noah M. Hahn, MD, Associate Professor of Medicine, Department of Oncology and Urology, Johns Hopkins University School of Medicine

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.